Organisation paid for research Program year 2025 Source: CMS Open Payments

Newco 3A Research LLC

Neither a doctor nor a teaching hospital

Research payments

$2,444,753

261 payments

Through program year 2025, Newco 3A Research LLC is reported as receiving $2,444,753 in research payments, across 261 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$486,448	38
2024	Research	$187,374	45
2023	Research	$542,131	58
2022	Research	$531,194	65
2021	Research	$697,605	55

Breakdown

Who paid Research payments · program years 2021–2025

Taro Pharmaceuticals USA, Inc. $899,125 81 payments
Teva Pharmaceuticals USA, Inc. $675,235 43 payments
Sun Pharmaceutical Industries Inc. $332,490 27 payments
AbbVie, Inc. $249,398 88 payments
Journey Medical Corporation $223,784 15 payments
Amgen Inc. $35,493 4 payments
Pfizer Inc. $29,229 3 payments

Studies the money was for Research payments · program years 2021–2025

Study $621,300 48 payments
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Design Group Study to Evaluate the Therapeutic Equivalence Comparing Trifarotene Cream, 0.005% (Teva Pharmaceuticals, Inc. to Aklief (Trifarotene 0.005% Cream) (Galderma Laboratories, L.P., USA), in the Treatment of Acne Vulgaris $482,600 31 payments
Dfd-29-Cd-006 $223,784 15 payments
Study Comparing Tapinarof Cream 1% To VTAMA (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis $192,635 12 payments
RXLC 2118 $181,155 20 payments
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN‑A MICRO® Gel Microsphere 0.04% in the Treatment of Acne Vulgaris $176,245 8 payments
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) $67,022 18 payments
Tpnc-2412 $59,460 4 payments
THRC 2026 $53,300 7 payments
HLBT 2001 $45,350 11 payments

What the money was spent on Research payments · program years 2021–2025

Patient care $161,490 10 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.